199 related articles for article (PubMed ID: 36399014)
1. An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in
Chua KJ; Ling H; Hwang IY; Lee HL; March JC; Lee YS; Chang MW
ACS Biomater Sci Eng; 2023 Sep; 9(9):5123-5135. PubMed ID: 36399014
[TBL] [Abstract][Full Text] [Related]
2. Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut.
Praveschotinunt P; Duraj-Thatte AM; Gelfat I; Bahl F; Chou DB; Joshi NS
Nat Commun; 2019 Dec; 10(1):5580. PubMed ID: 31811125
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Serotonin-Related Genes by Extracellular Vesicles of the Probiotic
Olivo-Martínez Y; Martínez-Ruiz S; Cordero-Alday C; Bosch M; Badia J; Baldoma L
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791376
[TBL] [Abstract][Full Text] [Related]
4. Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
Liang M; Zhang J; Yang Y; Xia Y; Liu L; Liu L; Wang Q; Gao X
World J Microbiol Biotechnol; 2022 Nov; 39(1):8. PubMed ID: 36350434
[TBL] [Abstract][Full Text] [Related]
5. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan-alginate matrix by combining layer-by-layer assembly with CaCl
Luo X; Song H; Yang J; Han B; Feng Y; Leng Y; Chen Z
Colloids Surf B Biointerfaces; 2020 May; 189():110818. PubMed ID: 32018138
[TBL] [Abstract][Full Text] [Related]
7. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery.
Li M; Liu N; Zhu J; Wu Y; Niu L; Liu Y; Chen L; Bai B; Miao Y; Yang Y; Chen Q
Biomaterials; 2024 Sep; 309():122584. PubMed ID: 38735180
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli Nissle 1917 ghosts alleviate inflammatory bowel disease in zebrafish.
Chen H; Lei P; Ji H; Ma J; Fang Y; Yu H; Du J; Qu L; Yang Q; Luo L; Zhang K; Wu W; Jin L; Sun D
Life Sci; 2023 Sep; 329():121956. PubMed ID: 37473802
[TBL] [Abstract][Full Text] [Related]
9. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery.
Zhou J; Li M; Chen Q; Li X; Chen L; Dong Z; Zhu W; Yang Y; Liu Z; Chen Q
Nat Commun; 2022 Jun; 13(1):3432. PubMed ID: 35701435
[TBL] [Abstract][Full Text] [Related]
10. Probiotic Escherichia coli Nissle 1917-derived outer membrane vesicles enhance immunomodulation and antimicrobial activity in RAW264.7 macrophages.
Hu R; Lin H; Li J; Zhao Y; Wang M; Sun X; Min Y; Gao Y; Yang M
BMC Microbiol; 2020 Aug; 20(1):268. PubMed ID: 32854612
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
12. Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients.
Jensen SR; Mirsepasi-Lauridsen HC; Thysen AH; Brynskov J; Krogfelt KA; Petersen AM; Pedersen AE; Brix S
Int J Med Microbiol; 2015 Dec; 305(8):925-36. PubMed ID: 26522075
[TBL] [Abstract][Full Text] [Related]
13. Effects of Lactobacillus rhamnosus GG and Escherichia coli Nissle 1917 Cell-Free Supernatants on Modulation of Mucin and Cytokine Secretion on Human Intestinal Epithelial HT29-MTX Cells.
Wan ML; Chen Z; Shah NP; El-Nezami H
J Food Sci; 2018 Jul; 83(7):1999-2007. PubMed ID: 29863797
[TBL] [Abstract][Full Text] [Related]
14. Probiotic
Teng G; Liu Z; Liu Y; Wu T; Dai Y; Wang H; Wang W
Front Microbiol; 2022; 13():819336. PubMed ID: 35602072
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7.
Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA
Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798
[TBL] [Abstract][Full Text] [Related]
16. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
17. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells.
Güttsches AK; Löseke S; Zähringer U; Sonnenborn U; Enders C; Gatermann S; Bufe A
Innate Immun; 2012 Apr; 18(2):204-16. PubMed ID: 21382908
[TBL] [Abstract][Full Text] [Related]
19. The effect of probiotic Escherichia coli strain Nissle 1917 lipopolysaccharide on the 5-aminosalicylic acid transepithelial transport across Caco-2 cell monolayers.
Stětinová V; Smetanová L; Kholová D; Květina J; Svoboda Z; Zídek Z; Tlaskalová-Hogenová H
Gen Physiol Biophys; 2013 Sep; 32(3):371-80. PubMed ID: 23846256
[TBL] [Abstract][Full Text] [Related]
20. The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice.
Garrido-Mesa N; Utrilla P; Comalada M; Zorrilla P; Garrido-Mesa J; Zarzuelo A; Rodríguez-Cabezas ME; Gálvez J
Biochem Pharmacol; 2011 Dec; 82(12):1891-900. PubMed ID: 21930116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
